Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF 1.56% Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmo Pharmaceuticals NV
Net Income (Common) Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Net Income (Common)
€75.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Perrigo Company PLC
NYSE:PRGO
Net Income (Common)
-$159.7m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Net Income (Common)
$463.2m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
31%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Net Income (Common)
-$106.2m
CAGR 3-Years
-24%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
G
GH Research PLC
NASDAQ:GHRS
Net Income (Common)
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Net Income (Common)
-€3.6m
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
8%

See Also

What is Cosmo Pharmaceuticals NV's Net Income (Common)?
Net Income (Common)
75.7m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Net Income (Common) amounts to 75.7m EUR.

What is Cosmo Pharmaceuticals NV's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-1%

Over the last year, the Net Income (Common) growth was 598%.

Back to Top